Trial intelligence / Profile preview

Adductor Canal vs Femoral Nerve Block for Knee Arthroscopy

NCT05190120Phase 4Completed

Sponsor
University of California, San Francisco
Start
Jan 2016
Primary completion
Mar 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Change in Quadriceps Strength Related to the Nerve Block. Started Jan 2016; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05190120.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05190120.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call